Cencora, Inc.

Cencora stock: Company schedules fiscal 2026 fourth-quarter results for November 4

Published on 10/06/2026 at 21:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora plans to release its fiscal 2026 fourth-quarter results on November 4. The company also added Robert E. Sanchez as an independent director effective October 1.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks
Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora plans to release its fiscal 2026 fourth-quarter results on Wednesday, November 4, 2026, before trading opens on the New York Stock Exchange. The company said it will host a conference call to discuss the results at 8:30 a.m. ET that day.

Cencora adds independent director

In a September 25, 2026 release, Cencora announced that its board elected Robert E. Sanchez as an independent director effective October 1. Sanchez is executive chair of Ryder System and previously served as that company’s chair and chief executive officer until retiring in March 2026.

Cencora said Sanchez’s experience in public-company leadership, operations, finance and technology would add insight as the company advances its priorities. The related SEC filing states that his appointment increased the board from ten to eleven members and that he had not been assigned to a board committee at the time of the filing.

Disclaimer...

en | boerse | 70245790 |